Livent (LTHM) & Its Competitors Critical Survey

Share on StockTwits

Livent (NYSE: LTHM) is one of 27 publicly-traded companies in the “Chemicals & allied products” industry, but how does it compare to its competitors? We will compare Livent to related businesses based on the strength of its profitability, institutional ownership, risk, earnings, analyst recommendations, valuation and dividends.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Livent and its competitors, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Livent 2 6 6 0 2.29
Livent Competitors 226 764 995 45 2.42

Livent currently has a consensus target price of $15.08, indicating a potential upside of 117.34%. As a group, “Chemicals & allied products” companies have a potential upside of 20.44%. Given Livent’s higher possible upside, equities research analysts clearly believe Livent is more favorable than its competitors.

Institutional & Insider Ownership

98.0% of Livent shares are owned by institutional investors. Comparatively, 72.3% of shares of all “Chemicals & allied products” companies are owned by institutional investors. 0.7% of Livent shares are owned by insiders. Comparatively, 8.9% of shares of all “Chemicals & allied products” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Livent and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Livent 19.88% 19.98% 14.87%
Livent Competitors -44.39% 20.04% 5.39%

Valuation & Earnings

This table compares Livent and its competitors top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Livent $442.50 million $126.10 million 7.63
Livent Competitors $7.43 billion $509.65 million 12.61

Livent’s competitors have higher revenue and earnings than Livent. Livent is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summary

Livent competitors beat Livent on 8 of the 12 factors compared.

Livent Company Profile

Livent Corporation manufactures and sells performance lithium compounds that are used primarily in energy storage, specialty polymers, and chemical synthesis application. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and supplies butyllithium, which is used as a synthesizer in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in the production of lightweight materials for aerospace applications and non-rechargeable batteries. Livent Corporation was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.

Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.